Volume 16, Issue 6 (Nov & Dec- In press 2026)                   J Research Health 2026, 16(6): 12-12 | Back to browse issues page

Ethics code: IR.TUMS.IKHC.REC.1403.150


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sanagouye Moharer G, khaneghahi S, khomri S, saljoughi M, shayeste Y, Zarei Talebi F et al . The Effect of Virtual Reality on Pain and Comfort in Women with Breast Cancer Undergoing Chemotherapy: A Randomized Controlled Trial. J Research Health 2026; 16 (6) :12-12
URL: http://jrh.gmu.ac.ir/article-1-3005-en.html
1- Department of psychology, ZAH.C., Islamic Azad University, Zahedan, Iran
2- School of General Psychology, zabol university of Medical Sciences, Zabol, Iran
3- Department of psychology ، ZAH.c ، Islamic Azad university ، Zahedan، Iran , mahboubehsaljoughi@gmail.com
4- Department of psychology ، ZAH.c ، Islamic Azad university ، Zahedan، Iran
5- Department of Clinical Psychology, Tehran University of Medical Sciences, Tehran, Iran
Abstract:   (24 Views)
Cancer is the third leading cause of death worldwide and is considered a major group of chronic non-communicable diseases. This study aimed to investigate the effectiveness of virtual reality (VR) as a non-pharmacological intervention on pain and comfort among women with breast cancer undergoing chemotherapy. This randomized controlled interventional study was conducted on 100 women with breast cancer receiving chemotherapy at Imam Khomeini Hospital, Tehran, in 2024. Participants were selected using convenience sampling and randomly allocated to intervention (n = 50) and control (n = 50) groups. The intervention consisted of a single 15-minute VR session using Samsung Gear VR at the beginning of chemotherapy infusion, while the control group received routine care. Pain and comfort were assessed before and after the intervention using the McGill Pain Questionnaire and the Holistic Comfort Questionnaire (HCQ), respectively. Data were analyzed using independent t-tests and one-way ANOVA. The post-intervention comfort score was significantly higher in the intervention group compared with the control group (p < 0.001), while no significant difference was observed before the intervention (p = 0.59). In addition, the mean post-intervention pain score was significantly lower in the intervention group than in the control group (p < 0.001). These findings suggest that VR is an effective, safe, and low-cost complementary approach for reducing pain and improving comfort in women with breast cancer undergoing chemotherapy
     
Type of Study: Short Communication | Subject: ● Health Education
Received: 2025/12/11 | Accepted: 2026/06/10 | Published: 2026/11/4

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Journal of Research and Health

Designed & Developed by : Yektaweb